Showing 1 - 10 of 2,339
Persistent link: https://www.econbiz.de/10011606135
Persistent link: https://www.econbiz.de/10013449296
Persistent link: https://www.econbiz.de/10013435486
Persistent link: https://www.econbiz.de/10010403289
Persistent link: https://www.econbiz.de/10011427811
Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...
Persistent link: https://www.econbiz.de/10010229875
Patent-based measures are frequently used as indicators in empirical research on innovation and technology as well as on firms' strategies and organizational choices to characterize inventions or, more generally, innovative activities and the technological capabilities of organizations. A clear...
Persistent link: https://www.econbiz.de/10010258420
Patent-based measures are frequently used as indicators in empirical research on innovation and technological change. Currently, there is little evidence as to what extent patent-based indicators relate to product market outcomes. Using a unique dataset that links outcomes from product...
Persistent link: https://www.econbiz.de/10010497622
Persistent link: https://www.econbiz.de/10013170079
How does a firm’s market power in existing products affect its incentives to innovate? We explore this fundamental question using granular project-level and firm-level data from the pharmaceutical industry, focusing on a particular mechanism through which incumbent firms maintain their market...
Persistent link: https://www.econbiz.de/10012818283